[
  {
    "ts": "2025-10-24T21:45:03+00:00",
    "headline": "Moderna (MRNA) Outperforms Broader Market: What You Need to Know",
    "summary": "Moderna (MRNA) reached $26.74 at the closing of the latest trading day, reflecting a +1.87% change compared to its last close.",
    "url": "https://finance.yahoo.com/news/moderna-mrna-outperforms-broader-market-214503388.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "56e973df-c36a-31d7-818c-2bc801201b71",
      "content": {
        "id": "56e973df-c36a-31d7-818c-2bc801201b71",
        "contentType": "STORY",
        "title": "Moderna (MRNA) Outperforms Broader Market: What You Need to Know",
        "description": "",
        "summary": "Moderna (MRNA) reached $26.74 at the closing of the latest trading day, reflecting a +1.87% change compared to its last close.",
        "pubDate": "2025-10-24T21:45:03Z",
        "displayTime": "2025-10-24T21:45:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/670d1917693293f70179651625deb88f",
          "originalWidth": 900,
          "originalHeight": 675,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/T5hbaObWi1jST2y00rKbhQ--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/670d1917693293f70179651625deb88f.cf.webp",
              "width": 900,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Oc5UMRa8ji_BfGLG4u5KZw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/670d1917693293f70179651625deb88f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/moderna-mrna-outperforms-broader-market-214503388.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/moderna-mrna-outperforms-broader-market-214503388.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-24T01:15:32+00:00",
    "headline": "How Investors May Respond To Moderna (MRNA) Halting Development of mRNA-1647 CMV Vaccine",
    "summary": "Moderna announced in October 2025 that it will discontinue development of its investigational cytomegalovirus (CMV) vaccine, mRNA-1647, following disappointing results from a Phase 3 clinical trial that did not meet its primary efficacy endpoint in seronegative women of childbearing age. This decision marks a setback for one of Moderna’s most advanced late-stage programs, highlighting the ongoing risks and volatility inherent in late-stage vaccine development. We’ll assess how discontinuing...",
    "url": "https://finance.yahoo.com/news/investors-may-respond-moderna-mrna-011532187.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "a41cf095-0f16-3f7d-9b5e-f8920355f883",
      "content": {
        "id": "a41cf095-0f16-3f7d-9b5e-f8920355f883",
        "contentType": "STORY",
        "title": "How Investors May Respond To Moderna (MRNA) Halting Development of mRNA-1647 CMV Vaccine",
        "description": "",
        "summary": "Moderna announced in October 2025 that it will discontinue development of its investigational cytomegalovirus (CMV) vaccine, mRNA-1647, following disappointing results from a Phase 3 clinical trial that did not meet its primary efficacy endpoint in seronegative women of childbearing age. This decision marks a setback for one of Moderna’s most advanced late-stage programs, highlighting the ongoing risks and volatility inherent in late-stage vaccine development. We’ll assess how discontinuing...",
        "pubDate": "2025-10-24T01:15:32Z",
        "displayTime": "2025-10-24T01:15:32Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/759f0ca28b885d5d534769cdaccce534",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lV6Oo0M_C3X63uXoBkpnwQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/759f0ca28b885d5d534769cdaccce534.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KdbFtaQiMRVA6Enl712wNA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/759f0ca28b885d5d534769cdaccce534.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/investors-may-respond-moderna-mrna-011532187.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/investors-may-respond-moderna-mrna-011532187.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]